Bio-XCell, Agila Biotech team up for RM107M facility in Johor

Bio-XCell Sdn Bhd and Agila Biotech Sdn Bhd have sealed a RM107 million build-and-lease agreement, to jointly develop a customized biotech facility in Nusajaya, Johor. Bio-XCell will provide RM67.32 million under the agreement with Agila Biotech, which covers the building construction and part of the equipment.

Meanwhile, Agila Biotech will fund all other related state-of-the-art equipment, integration service and testing of this turnkey project (about US$13 million to US$15 million). Bio-Xcell said work on the facility for the end-to-end manufacturing of biologics is expected to start as soon as possible.The research and development (R&D) and manufacturing facilities are expected to be operational by end 2014.

Agila Biotech (Malaysia) plans to incorporate into its facilityat Bio-XCell, the "next-generation" technology platforms which revolutionise the way biomolecules are developed, manufactured, and commercialized.Agila Biotech (Malaysia) joins Biocon (India), MetEx (France) and Glycos Biotechnologies (USA) as the early entrants into the Bio-XCellecosystem. The ecosystem at Bio-XCell is designed for industrial and healthcare biotechnology with a focus on manufacturing and R&D.

For more information on this, contact Bio-Xcell at +603 2116 855 / +607 277 3647 or drop them an email at info@bio-xcell.my.